Scarica l'app Stockscreener
49.23
4.26%
-2.19
Pre-mercato:
49.80
0.57
+1.16%
Precedente Chiudi:
$51.42
Aprire:
$50.31
Volume 24 ore:
1.45M
Relative Volume:
1.10
Capitalizzazione di mercato:
$1.52B
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.8132
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
+12.01%
1M Prestazione:
+28.17%
6M Prestazione:
+175.80%
1 anno Prestazione:
+229.08%
Intervallo 1D:
$48.08
$50.65
Intervallo di 1 settimana:
$44.10
$52.56
Portata 52W:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
49.23 | 1.52B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
421.47 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
201.10 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.65 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.45 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
162.61 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
Grail plans to submit updated Galleri blood test for FDA approval next year - Fierce Biotech
Grail stock gains on new data for Galleri cancer test (GRAL) - Seeking Alpha
GRAIL reports positive results from cancer detection test study By Investing.com - Investing.com Nigeria
GRAIL reports positive results from cancer detection test study - Investing.com Australia
GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study - MarketScreener
Grail reports results from PATHFINDER 2 study - TipRanks
Revolutionary Cancer Screening Test Achieves Major Clinical Success: GRAIL's Galleri Outperforms Previous Study - Stock Titan
GRAIL: Too Much A Leap Of Faith (NASDAQ:GRAL) - Seeking Alpha
California State Teachers Retirement System Takes $464,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
67,288 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
NINGI short Grail, says ‘approval and commercialization all but impossible’ - TipRanks
GRAIL stock tumbles on short-seller report By Investing.com - Investing.com Nigeria
GRAIL stock tumbles on short-seller report - Investing.com
Ningi Research Says Short Grail - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - inkl
GRALGRAIL Reports First Quarter 2025 Financial Results - mx.advfn.com
Wellington Management Group LLP Takes Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Two Sigma Advisers LP Makes New $345,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
For FMCG Inc., the holy grail of volume growth is in sight | Company Business News - Mint
Nuveen Asset Management LLC Takes $837,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Transcript : GRAIL, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11 - marketscreener.com
BNP Paribas Financial Markets Invests $50,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Ameriprise Financial Inc. Takes $681,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL, Inc. (GRAL) Stock Analysis: Evaluating the 19.10% Revenue Growth Against Market Challenges - DirectorsTalk Interviews
96,630 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Two Sigma Investments LP - Defense World
GRAIL announces inducement grants - Medical Buyer
Grail Inc. stockholders elect director, ratify auditor By Investing.com - Investing.com Nigeria
Grail Inc. stockholders elect director, ratify auditor - Investing.com
GRAIL Inc Holds Annual Stockholders Meeting - TipRanks
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail (GRAL) and Its Competitors Head-To-Head Analysis - Defense World
Rêve Health to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test - Fitt Insider
Millennium Management LLC Takes $5.28 Million Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
(GRAL) Technical Data - news.stocktradersdaily.com
Man Group plc Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
56,062 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Deutsche Bank AG - Defense World
145,949 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Northern Trust Corp - Defense World
Janus Henderson Group PLC Invests $223,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
595,962 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Bank of America Corp DE - Defense World
Early Cancer Detection Pioneer GRAIL Reveals Latest Advances at Major Healthcare Conference - Stock Titan
GRAIL to Present at Jefferies Global Healthcare Conference 2025 - PR Newswire
Liquid Biopsy Market Is Booming So Rapidly | GRAIL, Freenome, Natera - openPR.com
How to Take Advantage of moves in (GRAL) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL falls 16% after Q1 topline miss - MSN
GRAIL First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biotech startup Grail (GRAL) gets grilled on its cash burn - Investorsobserver
Gravity study shows why the moon's two sides look so different - marketscreener.com
Health Care Sector Slips While Incannex Rockets Ahead - Finimize
Sector Update: Health Care - marketscreener.com
GRAIL and athenahealth partner to simplify ordering of cancer detection test - MSN
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
2.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):